Jagsonpal Pharmaceuticals Limited
Jagsonpal Pharmaceuticals Limited engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally. It offers pharmaceutical formulations and products in the areas of gynaecology, orthopaedics, dermatology, and paediatrics. The company provides drugs in the form of tablets, softgels, injections, capsules, and syrups. … Read more
Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.098x
Based on the latest financial reports, Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) has a cash flow conversion efficiency ratio of 0.098x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₹246.75 Million) by net assets (₹2.53 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Jagsonpal Pharmaceuticals Limited - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how Jagsonpal Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Jagsonpal Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jagsonpal Pharmaceuticals Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ray Co. Ltd
KQ:228670
|
0.053x |
|
Jaanh CosmeticsInc.
KQ:219550
|
-0.295x |
|
Tristar Gold
OTCQB:TSGZF
|
-0.024x |
|
Artiva Biotherapeutics, Inc. Common Stock
NASDAQ:ARTV
|
-0.149x |
|
Prostemics Co. Ltd
KQ:203690
|
-0.143x |
|
CHA Vaccine Institute Co. Ltd.
KQ:261780
|
-0.140x |
|
Intchains Group Limited American Depositary Shares
NASDAQ:ICG
|
-0.020x |
|
ONDE S.A. ZY -02
F:0XF
|
N/A |
Annual Cash Flow Conversion Efficiency for Jagsonpal Pharmaceuticals Limited (2006–2025)
The table below shows the annual cash flow conversion efficiency of Jagsonpal Pharmaceuticals Limited from 2006 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | ₹2.40 Billion | ₹553.00 Million | 0.230x | +22.82% |
| 2024-03-31 | ₹1.87 Billion | ₹351.66 Million | 0.188x | -36.09% |
| 2023-03-31 | ₹1.59 Billion | ₹466.54 Million | 0.294x | +586.35% |
| 2022-03-31 | ₹1.31 Billion | ₹55.98 Million | 0.043x | -81.52% |
| 2021-03-31 | ₹1.22 Billion | ₹282.22 Million | 0.231x | +128.51% |
| 2020-03-31 | ₹1.11 Billion | ₹112.47 Million | 0.101x | -65.75% |
| 2019-03-31 | ₹1.04 Billion | ₹308.98 Million | 0.296x | +1940.07% |
| 2018-03-31 | ₹980.47 Million | ₹-15.76 Million | -0.016x | +45.50% |
| 2017-03-31 | ₹1.10 Billion | ₹-32.41 Million | -0.029x | -132.09% |
| 2016-03-31 | ₹983.64 Million | ₹90.39 Million | 0.092x | +104.01% |
| 2015-03-31 | ₹954.26 Million | ₹42.98 Million | 0.045x | -40.94% |
| 2014-03-31 | ₹985.89 Million | ₹75.18 Million | 0.076x | -37.74% |
| 2013-03-31 | ₹983.71 Million | ₹120.50 Million | 0.122x | +70.29% |
| 2012-03-31 | ₹984.69 Million | ₹70.83 Million | 0.072x | +3.52% |
| 2011-03-31 | ₹929.14 Million | ₹64.56 Million | 0.069x | +611.50% |
| 2010-03-31 | ₹875.70 Million | ₹8.55 Million | 0.010x | -95.61% |
| 2009-03-31 | ₹801.68 Million | ₹178.16 Million | 0.222x | +198.39% |
| 2008-03-31 | ₹750.34 Million | ₹55.88 Million | 0.074x | +127.99% |
| 2007-03-31 | ₹724.98 Million | ₹23.68 Million | 0.033x | +44.65% |
| 2006-03-31 | ₹702.35 Million | ₹15.86 Million | 0.023x | -- |